Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $2.68 billion. The enterprise value is $5.96 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SGRY has 126.38 million shares outstanding. The number of shares has increased by 5.30% in one year.
Current Share Class | 126.38M |
Shares Outstanding | 126.38M |
Shares Change (YoY) | +5.30% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 1.27% |
Owned by Institutions (%) | 70.75% |
Float | 74.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 23.36 |
PS Ratio | 0.90 |
Forward PS | 0.79 |
PB Ratio | 1.41 |
P/TBV Ratio | n/a |
P/FCF Ratio | 16.41 |
P/OCF Ratio | 10.67 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 10.01, with an EV/FCF ratio of 36.50.
EV / Earnings | n/a |
EV / Sales | 2.00 |
EV / EBITDA | 10.01 |
EV / EBIT | 13.37 |
EV / FCF | 36.50 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.99.
Current Ratio | 1.80 |
Quick Ratio | 1.37 |
Debt / Equity | 0.99 |
Debt / EBITDA | 5.15 |
Debt / FCF | 21.58 |
Interest Coverage | 2.53 |
Financial Efficiency
Return on equity (ROE) is 3.08% and return on invested capital (ROIC) is 4.16%.
Return on Equity (ROE) | 3.08% |
Return on Assets (ROA) | 3.90% |
Return on Capital (ROIC) | 4.16% |
Revenue Per Employee | $221,133 |
Profits Per Employee | -$4,489 |
Employee Count | 13,500 |
Asset Turnover | 0.42 |
Inventory Turnover | 30.11 |
Taxes
In the past 12 months, SGRY has paid $19.80 million in taxes.
Income Tax | 19.80M |
Effective Tax Rate | 15.76% |
Stock Price Statistics
The stock price has decreased by -34.79% in the last 52 weeks. The beta is 2.58, so SGRY's price volatility has been higher than the market average.
Beta (5Y) | 2.58 |
52-Week Price Change | -34.79% |
50-Day Moving Average | 26.13 |
200-Day Moving Average | 27.46 |
Relative Strength Index (RSI) | 41.64 |
Average Volume (20 Days) | 1,330,994 |
Short Selling Information
The latest short interest is 11.19 million, so 8.86% of the outstanding shares have been sold short.
Short Interest | 11.19M |
Short Previous Month | 10.07M |
Short % of Shares Out | 8.86% |
Short % of Float | 14.96% |
Short Ratio (days to cover) | 8.61 |
Income Statement
In the last 12 months, SGRY had revenue of $2.99 billion and -$60.60 million in losses. Loss per share was -$0.48.
Revenue | 2.99B |
Gross Profit | 705.60M |
Operating Income | 446.10M |
Pretax Income | -15.40M |
Net Income | -60.60M |
EBITDA | 595.90M |
EBIT | 446.10M |
Loss Per Share | -$0.48 |
Full Income Statement Balance Sheet
The company has $243.50 million in cash and $3.53 billion in debt, giving a net cash position of -$3.28 billion or -$25.98 per share.
Cash & Cash Equivalents | 243.50M |
Total Debt | 3.53B |
Net Cash | -3.28B |
Net Cash Per Share | -$25.98 |
Equity (Book Value) | 3.55B |
Book Value Per Share | 15.00 |
Working Capital | 460.60M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $251.30 million and capital expenditures -$87.90 million, giving a free cash flow of $163.40 million.
Operating Cash Flow | 251.30M |
Capital Expenditures | -87.90M |
Free Cash Flow | 163.40M |
FCF Per Share | $1.29 |
Full Cash Flow Statement Margins
Gross margin is 23.64%, with operating and profit margins of 14.94% and -2.03%.
Gross Margin | 23.64% |
Operating Margin | 14.94% |
Pretax Margin | 4.21% |
Profit Margin | -2.03% |
EBITDA Margin | 19.96% |
EBIT Margin | 14.94% |
FCF Margin | 5.47% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.30% |
Shareholder Yield | -5.30% |
Earnings Yield | -2.26% |
FCF Yield | 6.09% |
Dividend Details Analyst Forecast
The average price target for SGRY is $37.38, which is 76.16% higher than the current price. The consensus rating is "Buy".
Price Target | $37.38 |
Price Target Difference | 76.16% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | 11.26% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SGRY has an Altman Z-Score of 1.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.1 |
Piotroski F-Score | 6 |